|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
Fall Managed Care Forum
Nov. 13-14, 2014
Las Vegas Nevada
Click here to visit the conference website.
Click Here to view the Journal of Managed Care Medicine
Click Here to view our Complimentary Online CME/CEU Webcasts
Journal of Managed Care Medicine new website released
The Journal of Managed Care Medicine (JMCM) has released its new website at www.jmcmpub.org. The website features current issues, past issues, supplements and much more. Be sure to visit the website for updates on the latest topics in managed care medicine.
If you are interested in advertising on the website or in JMCM, please click here.
| Share this article:
Fall Managed Care Forum 2014
The Fall Forum will feature the first Annual Innovation Awards for the NAMCP Medical Directors Institute, AAMCN and AAIHDS. If you are interested in applying for this award, please contact Katie Eads at email@example.com or 804-527-1905 and we will send you an application.
The Fall Forum will be held Nov., 12-13, 2014 at the Bellagio Resort in Las Vegas, Nevada for medical directors, nurses and administrators.
The Forum features up-to-date, useful information on the ACA and healthcare changes, trends and how to improve patient outcomes.
Click here to see the agenda, speakers, register and for more information on the conference.
Schizophrenia 'made up of 8 specific genetic disorders'
Medical News Today
Past studies have indicated that rather than being a single disease, schizophrenia is a collection of different disorders. Now, a new study by researchers at Washington University in St. Louis claims the condition consists of eight distinct genetic disorders, all of which present their own specific symptoms.
Study identifies genes tied to colon cancer
Colorectal cancer is one of the leading causes of death among populations around the world. While diet, physical activity and other lifestyle factors can influence the risk of developing the disease, hereditary factors also play an important role.
Researchers develop new type of genetic test for identifying developmental disorders
A large team of researchers with members from a host of countries across the globe has conducted an exhaustive study that has resulted in the development of a new genetic test to help identify development disorders in children. In their paper published in the journal Nature Genetics, the researchers describe their study, the results they found and what it might mean for children with development disorders in the near future.
What does a good day mean for your patients?
To find out how to feature your company in the GBEMTI eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
New gene variants for prostate cancer identified
HealthDay News via U.S. News & World Report
An international team of scientists has identified 23 new genetic variants linked to a greater risk for prostate cancer.
Although more research is needed, the researchers said their findings, which bring the total number of common gene variants associated with prostate cancer to 100, could help doctors diagnose the disease earlier and could lead to the development of new treatments.
Personalized medicine rests on cloud at HD Smith
We're all familiar with the typical pharmaceutical supply chain: A pharma company develops a drug and, after gaining FDA approval, mass produces it and distributes it to pharmacies. Physicians prescribe it. Potentially hundreds of thousands of patients walk into pharmacies armed with prescriptions and walk out with the drug. Age, weight, medical history, genome, and gender vary widely across potentially hundreds of thousands of patient-customers, but the drug is the same, with the possible exception of dosage.
Blood test for depression is 1st of its kind
The test identifies depression by measuring the levels of nine RNA blood markers, which are messengers that interpret DNA genetic codes and carry out their instructions. The blood test could also predicts which patients will benefit from cognitive behavioral therapy based on how some of these markers behave.
Stem cells used in landmark therapy for failing sight
A woman in Japan has received the first medical treatment based on induced pluripotent stem cells, eight years after they were discovered. The iPS cells were made by reprogramming skin cells from the woman's arm, then transformed into specialized eye cells to treat age-related macular degeneration,´ a condition that affects millions of elderly people worldwide, and often results in blindness.
The trials of stem cell therapy
The New York Times
Edgar Irastorza was just 31 when his heart stopped beating in October 2008. A Miami property manager, break-dancer and former high school wrestler, Irastorza had recently gained weight as his wife’s third pregnancy progressed. “I kind of got pregnant, too,” he said. During a workout one day, he felt short of breath and insisted that friends rush him to the hospital. Minutes later, his pulse flatlined.
Scientists 'reset' stem cells to study start of human development
British and Japanese scientists have managed to "reset" human stem cells to their earliest state, opening up a new realm of research into the start of human development and potentially life-saving regenerative medicines.
In work described by one independent expert as "a major step forward", the scientists said they had successfully rebooted pluripotent stem cells so they were equivalent to those of a seven to 10-day old embryo, before it implants in the womb.
EMERGING MEDICAL TECHNOLOGIES
Report: Apple's HealthKit will join medical trials
Apple's HealthKit, which enables health-related apps to share data with doctors, will be used in medical trials at two universities, according to a new report.
Stanford University Hospital and Duke University are organizing health trials that will rely on HealthKit to collect and disseminate data on participants' health metrics, Reuters reported.
App developers seek clearer US health data privacy guidelines
Reuters via Business Insider
Developers of apps for mobile devices are asking a U.S. agency to clarify its rules for protecting patient health information to reflect the fast-evolving technology. A consortium of startups including CareSync, AirStrip and AngelMD, sent a letter to Pennsylvania Republican Rep. Tom Marino, to express their frustration at the lack of developer-friendly online resources surrounding the privacy rules, known as HIPAA.
5 things preventing technology adoption in healthcare
The Stanford Medicine X conference is one of the most publicized events in healthcare. Its hashtag #MedX was a top-trending term on Twitter throughout last week’s event.
Every year, thought leaders, physicians, academics and entrepreneurs gather at MedX under common desire: To transform American healthcare through technology.
||MOST POPULAR ARTICLE
Bipolar disorder genes uncovered
Novel genes have been identified as possible contributors to bipolar disorder. The condition, also known as manic-depressive illness, is a chronic and devastating psychiatric illness, affecting 0.5-1.6 percent of the general population across their lifetime.
When cancer is in your genes
U.S. News & World Report
In many families, cancer genes are passed down through generations like an unwanted heirloom. But thanks to ever-improving genetic testing, doctors are able to identify these genes better than ever before — and offer patients treatment options to not only stop cancer from setting in, but to stop the gene from being passed on as well.
FDA: NEW TREATMENTS AND TECHNOLOGY
Orexigen wins US FDA approval for weight loss pill
Orexigen Therapeutics Inc. won U.S. approval for its obesity drug, making Contrave the third weight loss pill to hit the market in the last two years. The shares fell the most in three months as regulators required notice of potential health complications from the treatment.
FDA panel recommends approval of Novo Nordisk obesity treatment
The Wall Street Journal
Novo Nordisk said a U.S. Food and Drug Administration advisory panel recommended approval of the Danish drug maker's injectable diabetes drug as a treatment to fight obesity.
The diabetes treatment, known as Victoza, will be marketed as Saxenda if it is approved as an obesity drug.
Novo Nordisk said the advisory panel voted 14 to 1 in favor of approval.
ACCOUNTABLE CARE ORGANIZATIONS
Health literacy: A key ingredient for ACO success
Are your accountable care organization policies developed from a perspective that takes the degrees of health literacy of your covered lives into account? Does your ACO proactively foster an environment in which patients, regardless of degree of literacy, feel comfortable seeking help and asking questions?
Are ACOs solution or piece of healthcare fad diet?
Physicians News Digest
It’s no secret that the healthcare system in this country needs to go on a diet when it comes to costs. Currently, healthcare consumes almost 20% of the U.S. economy. In 1960, back when our healthcare system was more “fit and trim,” it only accounted for 5 percent of the U.S. economy. If this trend continues, healthcare will make up 100 percent of the U.S. economy by the time my children would qualify for Medicare. Needless to say, it’s time to go on a diet!
US works to step up Ebola aid, preps hospitals for potential patients
The Associated Press via Fox News
The American strategy on Ebola is two-pronged: Step up desperately needed aid to West Africa and, in an unusual step, train U.S. doctors and nurses for volunteer duty in the outbreak zone. At home, the goal is to speed up medical research and put hospitals on alert should an infected traveler arrive.
Health law has caveat on renewal of coverage
The New York Times
Millions of consumers will soon receive notices from health insurance companies stating that their coverage is being automatically renewed for 2015, along with the financial assistance they received this year from the federal government.
But consumer advocates and insurers say they see a significant potential for confusion because some of the information will be out of date and misleading on costs and other aspects of coverage.
Growing burden of employer-provider healthcare has accelerated under Obamacare
There’s been a fierce debate over whether Obamacare has increased health insurance premiums. Progressives have argued Obamacare is working due to modest projected premium increases on the exchanges for 2015. Conservatives have retorted that “there can be no doubt that healthcare today is more costly than it would have been without Obamacare.”
"Seizures can be caused by a number of factors, including epilepsy or fever, and most seizures stop themselves, according to the National Institutes of Health."
Missed last week's issue? See which articles your colleagues read most.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063